1. Home
  2. BXMT vs TARS Comparison

BXMT vs TARS Comparison

Compare BXMT & TARS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Blackstone Mortgage Trust Inc.

BXMT

Blackstone Mortgage Trust Inc.

HOLD

Current Price

$12.41

Market Cap

2.5B

Sector

Real Estate

ML Signal

HOLD

Logo Tarsus Pharmaceuticals Inc.

TARS

Tarsus Pharmaceuticals Inc.

HOLD

Current Price

$76.81

Market Cap

2.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BXMT
TARS
Founded
1966
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Medicinal Chemicals and Botanical Products
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.5B
2.7B
IPO Year
1998
2020

Fundamental Metrics

Financial Performance
Metric
BXMT
TARS
Price
$12.41
$76.81
Analyst Decision
Buy
Buy
Analyst Count
5
6
Target Price
$21.38
★ $89.00
AVG Volume (30 Days)
★ 2.0M
665.3K
Earning Date
04-29-2026
05-06-2026
Dividend Yield
★ 9.85%
N/A
EPS Growth
★ 154.70
48.21
EPS
★ N/A
N/A
Revenue
N/A
★ $451,360,000.00
Revenue This Year
N/A
$56.43
Revenue Next Year
N/A
$30.19
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
★ 146.71
52 Week Low
$12.31
$53.89
52 Week High
$20.67
$91.53

Technical Indicators

Market Signals
Indicator
BXMT
TARS
Relative Strength Index (RSI) 24.34 49.22
Support Level N/A $60.95
Resistance Level $14.27 $79.10
Average True Range (ATR) 0.34 2.72
MACD -0.05 -1.10
Stochastic Oscillator 9.28 13.08

Price Performance

Historical Comparison
BXMT
TARS

About BXMT Blackstone Mortgage Trust Inc.

Blackstone Mortgage Trust Inc is an externally managed real estate finance company that originates, acquires, and manages senior loans and other debt or credit-oriented investments collateralized by or relating to commercial real estate in North America, Europe, and Australia. Its portfolio is composed of senior loans secured by high-quality, institutional assets located in main markets, and sponsored by experienced, well-capitalized real estate investment owners and operators. The group finances its investments in a variety of ways, including borrowing under secured credit facilities, issuing collateralized loan obligations, or CLOs, other securitization transactions, syndicating senior loans and/or participations, and other forms of asset-level financing.

About TARS Tarsus Pharmaceuticals Inc.

Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.

Share on Social Networks: